Proof of Usefulness Report

Regentys

Analysis completed on 2/16/2026

+334
Proof of Usefulness Score
Certified Problem Solver

Regentys (formerly Asana Medical) is a legitimate regenerative medicine company developing ECMH for Ulcerative Colitis, acquired by Generex in 2019 for approximately $15M. However, the project submission contains significant inaccuracies, including false claims of mass user adoption ('most people') and vague audience definitions ('everyone'), which contradict its status as a clinical-stage medical device. While the technology is innovative and addresses a high-value medical need, the project lacks verifiable commercial traction or recent updates, suggesting potential stagnation or development hurdles.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+18.75
Audience Reach Impact+1.0
Technical Innovation+12.0
Evidence Of Traction+3.75
Market Timing Relevance+6.0
Functional Completeness+0.25
Subtotal+41.75
Usefulness Multiplierx0.8
Final Score+334

Project Details

Project URL
regentys.com
Description
Regentys (formerly Asana Medical, Inc.) is a regenerative medicine company developing a tissue engineered therapy for the treatment of Ulcerative Colitis (UC). The Company's product ECMH, a novel application of a proven technology, will be a first-in-class therapy for patients suffering from Ulcerative Colitis. This therapy will be positioned to compete in a multi-billion-dollar market dominated by biologic and drug therapies that can have significant side effects. Additionally, 20-30% of patients do not benefit from these therapies and have no alternative except colon removal surgery. Regentys has an experienced management team, strong patent protection, world-class advisors in business and medicine, and compelling preclinical proof-of-concept data. For more information, visit www.regentys.com.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline